A Safety Study of SGN-CD19A for Leukemia and Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eric Feldman, MD
Seagen Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital of Alabama / University of Alabama at Birmingham
Birmingham, Alabama, United States
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Mayo Clinic Arizona
Scottsdale, Arizona, United States
- City of Hope National Medical Center
Duarte, California, United States
- Mayo Clinic Florida
Jacksonville, Florida, United States
- All Children'S Hospital
St. Petersburg, Florida, United States
- H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, United States
- Children'S Healthcare of Atlanta / Emory University
Atlanta, Georgia, United States
- Boston Children'S Hospital
Boston, Massachusetts, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2013
- Primary completion
- 30 May 2017
- Completion
- 30 May 2017
- Last update posted
- 2 Jul 2017
- Registered enrollment
- 92
- Registry id
- NCT01786096
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.